Global Cancer Monoclonal Antibodies Market Size 2024, Forecast To 2033
11 Mar, 2024
The cancer monoclonal antibodies market size has witnessed rapid growth in recent years, surging from $59.98 billion in 2023 to $66.1 billion in 2024, reflecting a compound annual growth rate (CAGR) of 10.2%. This expansion in the historic period can be attributed to the flourishing growth in emerging markets, a notable increase in research and development (R&D) expenditure, a growing geriatric population, and a rising preference for biological treatments. Looking ahead to 2028, the market is anticipated to continue its robust trajectory, reaching $95.99 billion with a CAGR of 9.8%. The projected growth in the forecast period is influenced by factors such as the increasing prevalence of cancer, expanding global access to treatment, and a rise in healthcare expenditure, underlining persistent trends in product innovation through strategic collaborations, technological advancements, the development of humanized cancer monoclonal antibodies, investments in AI for R&D cost reduction, and substantial R&D investments.
Global Cancer Monoclonal Antibodies Market Key Driver
The growth of the cancer monoclonal antibody market is expected to be fueled by the increasing number of cancer cases globally. In January 2022, the American Cancer Society projected 1.9 million new cancer diagnoses and 609,360 cancer-related deaths in the US, averaging approximately 1,670 fatalities daily. The four most prevalent types of cancer worldwide—lung, prostate, bowel, and female breast cancer—comprise 43 percent of all new cancer cases. This surge in cancer incidence rates globally is poised to drive the demand for the cancer monoclonal antibody market, addressing the escalating need for effective treatment options.
Get A Free Sample Of The Global Cancer Monoclonal Antibodies Market ReportGlobal Cancer Monoclonal Antibodies Market Segments
The cancer monoclonal antibodies market covered in this report is segmented –
1) By Monoclonal Antibody Therapies: Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others
2) By Application: Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others
3) By End-User : Hospitals, Research Laboratories, Others
By Geography:The regions covered in the cancer monoclonal antibodies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
North America was the largest region in the cancer monoclonal antibodies market in 2023. The regions covered in the cancer monoclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Cancer Monoclonal Antibodies Industry Players
F. Hoffmann-La Roche Ltd, Merck & Co., Inc, Bristol Myers Squibb Company, Johnson & Johnson, Amgen Inc, AstraZeneca plc, Eli Lilly and Company, Pfizer Inc, Regeneron Pharmaceuticals Inc, Sanofi S.A, Innovent Biologics, Sino biological, Shanghai Henlius Biotech, Intas bio, Zydus Cadila, Ranbaxy, Takeda pharmaceuticals, AbbVie Inc, Biogen Idec, Bayer AG, Novartis AG, BiosanaPharma, WuXi, GlaxoSmithKline, Teva UK Limited, Abbott Laboratories, Fujifilm, Procos SpA, BSP Pharmaceuticals, Genmab, Insysbio, Rani Therapeutics, Emisphere Technologies, Inc, Enteris BioPharma, Allena Pharmaceuticals, Apotex, Gilead Sciences, Eurofarma, Teuto Brasileiro, BioMarin Pharmaceutical, BIONOVIS BRASIL, Ecopharm, Hypermarcas, Ache, Libbs Farmaceutica, Julphar, Spimaco Addwaeih, Hikma Pharmaceuticals, Tabuk, Novo Nordisk, BBI Solutions, APC Pharma, EPICIO, Medical Union Pharmaceuticals, South Egypt Drug Industries Co. Pharmaceutical, Vacsera Pharma, Aspen Pharmacare, Amoun Pharmaceuticals CO Ltd, 54gene, Baxter International, Altis Biologics, Cipla Medpro South Africa, Genzyme
Get The Full Global Cancer Monoclonal Antibodies Market Report
Cancer Monoclonal Antibodies Market Overview
Cancer monoclonal antibodies refer to a particular class of protein created in a lab that has the ability to bind to certain bodily targets, such as antigens on the surface of cancer cells. Each monoclonal antibody is designed to bind to a single antigen, and there are many different types of monoclonal antibodies.
Cancer Monoclonal Antibodies Global Market Report 2023 provides data on the global cancer monoclonal antibodies market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The cancer monoclonal antibodies market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.